Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mackenzie L. Bowman"'
Autor:
Robbie, Kloosterman, Matteo, Zago-Schmitt, Julie, Grabell, Lisa Ann, Thibeault, Patricia D A, Lima, Mackenzie L, Bowman, Kathrin, Tyryshkin, Charles C T, Hindmarch, Neil, Renwick, Paula D, James
Publikováno v:
Blood advances.
Type 1 von Willebrand disease (VWD) is associated with a reduction in qualitatively normal von Willebrand factor (VWF). Current diagnostic guidelines only take into consideration the contribution of basal VWF levels, despite a lack of correlation wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4ab865de78c3fd72890f5a5c86f31b1e
https://pubmed.ncbi.nlm.nih.gov/36121439
https://pubmed.ncbi.nlm.nih.gov/36121439
Autor:
Edwin K. Ocran, Erin Burnett, Mackenzie L. Bowman, Orla Rawley, Matthew Cormier, Donald Maurice, David Lillicrap, Paula D. James
Publikováno v:
Blood. 140:11222-11223
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d124e647c380bf3f92e43425ef6ca371
https://doi.org/10.1182/blood-2022-159053
https://doi.org/10.1182/blood-2022-159053
Publikováno v:
Blood. 122:3517-3517
Background Type 3 von Willebrand Disease (VWD) is the rarest and most severe form of the disease. Patients exhibit plasma von Willebrand factor (VWF) levels of Patients and Methods Peripheral blood samples were obtained from seven type 3 VWD index ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eaf8f9affc0c70195bf8fcd6df8668a0
https://doi.org/10.1182/blood.v122.21.3517.3517
https://doi.org/10.1182/blood.v122.21.3517.3517